Operose Advisors’s Medtronic MDT Stock Holding History

Operose Advisors's MDT Position: Q2 2026 in Review

Operose Advisors reduced its Medtronic (MDT) stake by 97% in Q2 2026, selling an estimated $24K and leaving 8 shares worth $626. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Operose Advisors first reported a position in MDT in Q1 2022 and has held it in 10 quarters since. The position peaked at $108K in Q3 2023. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

• Operose Advisors held 8 shares of Medtronic worth $626 as of Q2 2026.
• Operose Advisors sold 297 Medtronic shares in Q2 2026, an estimated $24K.
• Medtronic made up ﹤0.01% of Operose Advisors's portfolio in Q2 2026, its #498 holding.
• Operose Advisors first reported a position in Medtronic in Q1 2022 and has held it in 10 quarters since.
• Operose Advisors's Medtronic position peaked at $108K in Q3 2023.
• 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.